参考文献/References:
［1］American Association of Gynecologic Laparoscopists. AAGL practice report: practice guidelines for the diagnosis and management of endometrial polyps ［J］. J Minim Invasive Gynecol, 2011, 19(1): 3-10.
［2］Dreisler E, Stampe SS, Ibsen PH, et al. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years［J］. Ultrasound Obstet Gynecol, 2009(33): 102-108.
［3］Anastasiadis PG, Koutlaki NG, Skaphida PG,etal. Endometrial polyps:prevalence,detection,and malignant potential in women with abnormal uterine bleeding ［J］. Eur J Gynaecol Oncol, 2000(21): 180-183.
［4］Tokyol C , Aktepe F , Dilek,et al. Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis［J］. International Journal of Gynecological Pathology, 2009, 28(2):148-156.
［5］林彦娜，吴雪燕，刘夏云．绝经后子宫内膜息肉发病和恶变影响因素分析 ［J］．中国现代药物应用，2017，11（17）：87-89．
［6］De Carvalho S, Campaner AS, Lima SM, et al. Differential expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women［J］.Anal Quant Cytol Histol,2011,33(2):61-67.
［7］豆艳艳.ER和PR在绝经后子宫内膜息肉中的表达及其临床意义 ［J］. 中国妇幼保健, 2013, 28(18): 3020-3022.
［8］卢美松,李萌,汤小晗,等.半胱氨酸天冬氨酸蛋白酶-8和半胱氨酸天冬氨酸蛋白酶-3在子宫内膜息肉中的表达及相关性研究 ［J］.中国计划生育和妇产科,2018,10(1):19-22,36.
［9］Wethington SL, Herzogthomas J, Burkewilliam M, et al. Risk and predictors of malignancy in women with endometrial polyps ［J］. Climacteric, 2018, 21(1): 82-87.
［10］Domingues AP, Lopes H, Dias I, et al. Endometrial polyps in postmenopausal women［J］. Acta Obstet Gynecol Scand, 2009(88): 618-620.
［11］Costa-Paiva L, Godoy CE, AntunesA, et al. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics［J］. Menopause, 2011, 18(12): 1278-1282.
［12］陈艺华，修晓新．绝经后女性子宫内膜息肉发生癌前病变及癌的危险因素分析［J］．大连医科大学学报，2016，38（2）：151-154．
［13］王海波，逯彩虹，李萍，等．绝经后子宫内膜息肉恶变与代谢综合征的关系初探 ［J］．中国内镜杂志，2015，21（8）：819-822．
［14］Zhang Y，Chen M，GuoY S，et al.Clinical characters of pre-malignant and malignant polyp in postmenopausal women and the diagnostic value of hysteroscopy［J］.Zhonghua Fu Chan Ke Za Zhi，2016，51(5):366-370.
［15］Altaner S, Gucer F, Tokatli F, et al. Expression of Bcl-2 and Ki-67 in tamoxifen-associated endometrial polyps:comparison with postmenopausal polyps［J］. Onkologie, 2006, 29(8/9): 376-380.
［16］Botogoski SR，LimaSnia MR Rosa，GaloMaria AL，et al.Effects of tamoxifen on the expression of TGF-beta and p27 proteins in polyps and adjacent endometrium in postmenopausal women［J］.Rev Bras Ginecol Obstet，2009，31（3）:131-137.
［17］Miranda SP, Traiman P, Candido EB, et al. Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen［J］. International Journal of Gynecological Cancer, 2010, 20(9): 1525-1530.
［18］Antunes A , Andrade L A L A , Pinto G A , et al. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?［J］. Anal Quant Cytopathol Histpathol, 2012, 34(5):264-272.
［19］Antunes A, Vassallo J, PinheiroA, et al. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps:A comparison between benign and malignant polyps in postmenopausal patients［J］. Oncol Lett, 2014, 7(6): 1944-1950.
［20］De Godoy BP, DiasR, Bonassi MR, et al. Transvaginal ultrasonography and hysteroscopy as predictors of endometrial polyps in postmenopause ［J］. Womens Health(Lond), 2015, 11(1): 29-33.
［21］Burbos Nikolaos，Musonda Patrick，Crocker Simon G，et al.Management of postmenopausal women with vaginal bleeding when the endometrium can not be visualized［J］.Acta Obstet Gynecol Scand,2012,91(6):686-691.
［22］Laiyemo R, Dudill W, Jones SE, et al. Do postmenopausal women with thickened endometrium on trans-vaginal ultrasound in the absence of vaginal bleeding need hysteroscopic assessment? A Pilot Study ［J］. J Obstet Gynaecol (Lahore), 2016, 36(2): 223-226.
［23］从蓉俊,孔彩霞,符圆圆,等.曼月乐和达芙通预防子宫内膜息肉切除术后复发的效果比较［J］.中国计划生育和妇产科,2017,9(3):39-41,45.
［24］Jy P, Kim DY, Kim JH, et al. Long-term oncologic out-comes after fertility-sparing management using oral roges-tin for young women with endometrial cancer(KGOG2002)［J］. Eur J Cancer, 2013, 49(4): 868-874.
［25］王蔼明，尹善德，李敏，等．曼月乐治疗子宫内膜非典型增生的临床分析 ［J］．第四军医大学学报，2009，30（16）：1498-1500．
［26］Scrimin F，Mangino FP，WiesenfeldU，et al.Is resectoscopic treatment of atypical endometrial polyps a safe option? ［J］.Am J Obstet Gynecol,2006 ,195(5) :1328-1330.
［27］李琳，张慧．宫腔镜下行子宫内膜切除治疗绝经期子宫内膜息肉的临床研究［J］．临床合理用药杂志，2014，7（24）：107-108．
［28］邓蓉．钬激光联合输尿管镜在绝经后子宫内膜息肉患者中的临床应用［J］．中国现代医生，2016，54（5）：63-65．
［29］Genc M, Genc B, SahinN, et al. Endometrial pathology in postmenopausal women with no bleeding ［J］. Climacteric, 2015, 18(2): 241-245.
相似文献/References:
[1]白莎莎,庞义存,田腊梅,等.Maspin蛋白在葡萄胎恶变中的作用[J].中国计划生育和妇产科,2011,(06):0.
BAI Sha-sha,PANG Yi-cun,TIAN La-mei,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(10):0.
[2]姜桂芳.曼月乐预防子宫内膜息肉宫腔镜下切除术后复发的临床分析[J].中国计划生育和妇产科,2012,(02):0.
JIANG Gui-Fang.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(10):0.
[3]葛庆玲,李美,李延丽,等.宫腔镜联合B超在子宫内膜息肉诊断中的应用分析[J].中国计划生育和妇产科,2015,(01):0.
GE Qing-ling,LI Mei,LI Yan-li,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(10):0.
[4]宋芷霜,郭宝芝,刘爱珍,等.左炔诺孕酮宫内缓释系统预防子宫内膜息肉复发的临床观察[J].中国计划生育和妇产科,2015,(02):0.
SONG Zhi-shuang,GUO Bao-zhi,LIU Ai-zhen,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(10):0.
[5]陆洋,李慧,李晓红,等.子宫内膜息肉患者Th1/Th2细胞因子的血清学研究[J].中国计划生育和妇产科,2016,(01):0.
LU Yang,LI Hui,LI Xiao-hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(10):0.
[6]孙馥箐,段华.子宫内膜异位症不孕患者子宫内膜病变特征分析[J].中国计划生育和妇产科,2016,(07):0.
SUN Fu-qing,DUAN Hua,Minimally Invasive Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(10):0.
[7]从蓉俊*,孔彩霞,符圆圆,等.曼月乐和达芙通预防子宫内膜息肉切除术后复发的效果比较[J].中国计划生育和妇产科,2017,(3):39.
CONG Rong-jun*,KONG Cai-xia,FU Yuan- yuan,et al.Comparison of the effects of Mirena and Duphaston on prevention of recurrence after transcervical resection of polyp[J].Chinese Journal of Family Planning & Gynecotokology,2017,(10):39.
[8]孟萍萍,汤小晗,卢美松*.子宫内膜息肉复发机制的研究进展[J].中国计划生育和妇产科,2017,(5):33.
[9]庄文月,左欣,朱红娣*.宫腔镜引导选择性内膜切除子宫内膜息肉的综合疗效及复发率观察[J].中国计划生育和妇产科,2017,(7):44.
ZHUANG Wen-yue,ZUO Xin,ZHU Hong-di*.Therapeutic effect and recurrence rate of hysteroscopy guided selective endometrial resection of endometrial polyps[J].Chinese Journal of Family Planning & Gynecotokology,2017,(10):44.
[10]王利群,李萌,卢美松*.控制性超促排卵中新发子宫内膜息肉的研究进展[J].中国计划生育和妇产科,2017,(8):5.
[11]周怀君.子宫内膜息肉的药物治疗新进展[J].中国计划生育和妇产科,2021,(7):33.[doi:10.3969/j.issn.1674-4020.2021.07.11]
[J].Chinese Journal of Family Planning & Gynecotokology,2021,(10):33.[doi:10.3969/j.issn.1674-4020.2021.07.11]